Clinical trial Recruiting at 1 site Interventional Ages 45 to 64

Improving brain and heart health through a specific diet

Official title: Optimized Tailored Interventions in Metabolic and Lifestyle Outcomes: Examining the Effects of the Mediterranean-DASH Intervention for Neurodegenerative Delay(MIND) on Cognitive Performance, Metabolic Health and Lifestyle Outcomes Using Advanced Machine Learning Strategies

Run by University of Illinois at Urbana-Champaign · NCT06605898 · Data updated 2026-11-12

This study is testing if following the MIND diet can improve brain and heart health in middle-aged adults compared to a standard healthy diet.

Quick facts

Study typeInterventional
Ages45 Years to 64 Years
SexAll
Enrollment72 (estimated)
SponsorUniversity of Illinois at Urbana-Champaign
Academic / other
Locations1 site (Urbana, Illinois)
StatusRecruiting
StartedJuly 3, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedSeptember 20, 2024
Trial IDNCT06605898 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are middle-aged adults aged 45-64 who are cognitively intact and have no significant health issues or dietary restrictions.

Probably not a fit

Patients with neurological diseases, significant gastrointestinal issues, or those currently on specific medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine if adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet enhances cognitive performance and heart health compared to a standard healthy diet in middle-aged adults. Participants will be divided into three groups: one selected through predictive analytics, one following the MIND diet without pre-selection, and a control group on a standard healthy diet. Over 12 weeks, participants will receive daily meals and smoothies delivered to their homes and will complete various assessments, including memory tests and health evaluations. The study seeks to understand the effectiveness of the MIND diet and the role of predictive analytics in identifying those who may benefit most.

Why it matters

Potential benefit: If successful, this study could lead to improved dietary recommendations that enhance cognitive and cardiovascular health in middle-aged adults.

How similar studies have gone: Other studies have shown promising results with dietary interventions aimed at improving cognitive and heart health, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 45-64 years of age
* 20/20 or corrected vision
* No food allergies or intolerances
* Not pregnant, lactating, or have given birth in the past 12 months
* Do not smoke, use tobacco, or abuse drugs
* Absence of liver or gastrointestinal diseases (i.e., primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), hepatitis, HIV, and cancer
* Not currently taking oral hypoglycemic agents, or insulin
* No history of malabsorptive or bariatric surgery
* Cognitively intact with no prior diagnosis of neurological disease (i.e., mild cognitive impairment, Alzheimer's disease, vascular dementia, and/or Asperger's syndrome)
* Able to consume the study meals
* Not enrolled in another dietary, exercise, or medication study during the study.

Exclusion Criteria:

* Non-consent of participant
* Above 64 or below 45 years of age
* Vision not 20/20 or corrected
* Food allergies or intolerances
* Pregnant, lactating, or have given birth in the past 12 months
* Smoke, use tobacco, or abuse drugs
* Prior diagnosis of liver or gastrointestinal disease (i.e., primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), hepatitis, HIV, or cancer
* Currently taking oral hypoglycemic agents or insulin
* History of malabsorptive or bariatric surgery
* Cognitively impaired and/or prior diagnosis of neurological disease (i.e., mild cognitive impairment, Alzheimer's disease, vascular dementia, and/or Asperger's syndrome)
* Unable to consume the study meals
* Concurrent enrollment in another dietary, exercise, or medication study

Where it's running

  • University of Illinois at Urbana-Champaign
    Urbana, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Naiman Khan, PhD — University of Illinois Urbana-Champaign
  • Study coordinator: Naiman Khan, PhD
  • Email: nakhan2@illinois.edu
  • Phone: 2173001667

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.